Profil
Dr. Ole K.
Hjelstuen is Chief Executive Officer at Inven2 AS.
Postes actifs de Ole Kristian Hjelstuen
| Sociétés | Poste | Début |
|---|---|---|
Inven2 AS
 Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | Directeur Général | 01/04/2012 |
Anciens postes connus de Ole Kristian Hjelstuen
| Sociétés | Poste | Fin |
|---|---|---|
| ULTIMOVACS ASA | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ULTIMOVACS ASA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | Finance |
